Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 5, Issue 1, pp. 160-169
PubMed
Published By
Print ISSN
Online ISSN
History
- November 2, 2005
- June 17, 2005
- September 21, 2005
- Published first January 23, 2006.
Copyright & Usage
American Association for Cancer Research
Author Information
- Holly K. Koblish,
- Shuyuan Zhao,
- Carol F. Franks,
- Robert R. Donatelli,
- Rose M. Tominovich,
- Louis V. LaFrance,
- Kristi A. Leonard,
- Joan M. Gushue,
- Daniel J. Parks,
- Raul R. Calvo,
- Karen L. Milkiewicz,
- Juan José Marugán,
- Pierre Raboisson,
- Maxwell D. Cummings,
- Bruce L. Grasberger,
- Dana L. Johnson,
- Tianbao Lu,
- Christopher J. Molloy and
- Anna C. Maroney
- Requests for reprints: Holly K. Koblish, Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Welsh and McKean Roads, Spring House, PA 19477. Phone: 215-628-5449; Fax: 215-628-5047. E-mail: hkoblis1{at}prdus.jnj.com
January 2006
Volume 5, Issue 1
Volume 5, Issue 1
Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivo
Jump to section
Advertisement